CombiGene closer to clinical trials after oversubscribed issue

BioStock interviews CEO Jan Nilsson concerning the issue and the future
To interview (in Swedish) >>

“This is an English translation of the Swedish website; if there is any inconsistency or ambiguity between the English version and the Swedish version, the Swedish version shall prevail. For a complete list of regulatory-related press releases, please refer to the Swedish website”